Small molecules targeting phosphoinositide 3-kinases

The phosphoinositide 3-kinase (PI3K) pathway is one of the most important signalling cascades in cancer. It has been well established as an attractive oncology target and inhibitors of PI3K have been suggested as promising agents for therapeutic intervention in cancer. Since the discovery of wortmannin and LY294002, the first compounds to inhibit PI3K, a vast number of inhibitors have been identified.

This review from Peng Wu and Yongzhou Hu, Zhejiang University, outlines the current landscape of the development of small molecule PI3K inhibitors, with a focus on structure–activity relationships (SAR) and discussion of co-crystal structures of the twenty-two molecules that are currently under clinical trials and newly emerged ones.

Read the review and let us know your thoughts by commenting below on this blog!

Small molecules targeting phosphoinositide 3-kinases
Peng Wu and Yongzhou Hu
DOI: 10.1039/C2MD20044A

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

MedChemComm’s Natural Products themed issue now published online

Issue 8 of MedChemComm has arrived and it’s a Natural Products themed issue that is filled to bursting with: nine reviews elegantly summarising the synthesis, biosynthesis, inhibitory properties and targets, and biological functions of natural products, as well as new bioinformatics methods for their identification; and fourteen concise articles describing some of the newest discoveries in the field of natural products.


An example of such a concise article is featured on the inside cover of the issue:

Synthesis and anti-Helicobacter pylori activity of analogues of spirolaxine methyl ether
Ivaylo Dimitrov, Daniel P. Furkert, John D. Fraser, Fiona J. Radcliff, Orla Finch and Margaret A. Brimble
DOI: 10.1039/C2MD00314G

To check out the entire themed issue now click here…


A big thank you must go to the guest editors Professor Christopher Walsh (Harvard University) & Dr Sylvie Garneau-Tsodikova (University of Michigan) for all their hard work, and to all those who have contributed to this issue for making this issue such a success.

Finally, below is a cover suggestion from Amanda J. Hughes et al., which we really liked but which we were unfortunately unable to use on the cover, so we thought we would share it with you here.

Employing a polyketide synthase module and thioesterase in the semipreparative biocatalysis of diverse triketide pyrones
Amanda J. Hughes, Joshua F. Detelich and Adrian T. Keatinge-Clay
DOI: 10.1039/C2MD20013A

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Congratulations to Dr Patrick Gunning, recipient of the inaugural MedChemComm Emerging Investigator Lectureship

We are delighted to announce that Dr Patrick Gunning from the University of Toronto (Canada) is the recipient of the inaugural MedChemComm Emerging Investigator Lectureship.

The MedChemComm mission is to publish and promote research which pushes the boundaries of what is thought possible in medicinal chemistry, opening up new avenues of research. The committee felt Dr Gunning to be an outstanding candidate for the Lectureship, with his prominent work into the investigation and manipulation of protein function exemplifying the journal’s mission.

On receiving the Lectureship Dr Gunning said “I am absolutely delighted and honoured to be the recipient of the 2012 RSC MedChemComm Lectureship. It is a wonderful surprise!” Commenting on Dr Gunning’s Lectureship, Professor Andrew Hamilton, Vice Chancellor of Oxford University, said “Over the past several years Patrick has made an outstanding start to his independent research career. His work on disruptors of STAT3 function is both innovative and effective, and has the potential to open a new line of attack on some of the most aggressive cancers. I have also enjoyed reading his exciting and novel approach to targeting cancer through redirecting various oncoproteins from their targets to harmless anchoring into the cell membrane.”  

Dr Gunning will deliver the Lecture at an international conference in the next year. This will be announced in due course.

The MedChemComm Emerging Investigator Lectureship is an annual Lectureship which is given to a researcher who has made a significant contribution to medicinal chemistry research in the early part of their career. The recipient must also have published an article in MedChemComm. Nominations are received from members of the public and the recipient is chosen by a committee formed of members of the Editorial Board. Nominations for the 2013 Lectureship will open in late 2012.

View Dr Gunning’s recent  articles:

Src homology 2 domain proteomimetics: developing phosphopeptide selective receptors
Joel A. Drewry, Steven Burger, Amir Mazouchi, Eugenia Duodu, Paul Ayers, Claudiu C. Gradinaru and Patrick T. Gunning
Med. Chem. Commun., 2012, 3, 763-770

Inhibitors of Stat5 protein signalling
Abbarna A. Cumaraswamy, Aleksandra Todic, Diana Resetca, Mark D. Minden and Patrick T. Gunning
Med. Chem. Commun., 2012, 3, 22-27

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Top ten most accessed articles in June

This month sees the following articles in MedChemComm that are in the top ten most accessed:

The use of phosphate bioisosteres in medicinal chemistry and chemical biology
Thomas S. Elliott, Aine Slowey, Yulin Ye and Stuart J. Conway
Med. Chem. Commun., 2012, 3, 735-751
DOI: 10.1039/C2MD20079A

The developability of heteroaromatic and heteroaliphatic rings – do some have a better pedigree as potential drug molecules than others?
Timothy J. Ritchie, Simon J. F. Macdonald, Simon Peace, Stephen D. Pickett and Christopher N. Luscombe
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C2MD20111A

Minisci reactions: Versatile CH-functionalizations for medicinal chemists
Matthew A. J. Duncton
Med. Chem. Commun., 2011, 2, 1135-1161
DOI: 10.1039/C1MD00134E

Gd(III) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood–brain barrier permeable
Chang-Tong Yang and Kai-Hsiang Chuang
Med. Chem. Commun., 2012, 3, 552-565
DOI: 10.1039/C2MD00279E

Determination of drug–receptor residence times by radioligand binding and functional assays: experimental strategies and physiological relevance
Georges Vauquelin
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C2MD20015E

Towards biocompatible nanovalves based on mesoporous silica nanoparticles
Ying-Wei Yang
Med. Chem. Commun., 2011, 2, 1033-1049
DOI: 10.1039/C1MD00158B

Superiority of a novel EGFR targeted covalent inhibitor over its reversible counterpart in overcoming drug resistance
Juswinder Singh, Erica Evans, Margit Hagel, Matthew Labinski, Alex Dubrovskiy, Mariana Nacht, Russell C. Petter, Aravind Prasad, Michael Sheets, Thia St Martin, Robert Tjin Tham Sjin, William Westlin and Zhendong Zhu
Med. Chem. Commun., 2012, 3, 780-783
DOI: 10.1039/C2MD20017A

Molecular obesity, potency and other addictions in drug discovery
Michael M. Hann
Med. Chem. Commun., 2011, 2, 349-355
DOI: 10.1039/C1MD00017A

Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases
Thomas Beckers, Siavosh Mahboobi, Andreas Sellmer, Matthias Winkler, Emerich Eichhorn, Herwig Pongratz, Thomas Maier, Thomas Ciossek, Thomas Baer, Gerhard Kelter, Heinz-Herbert Fiebig and Mathias Schmidt
Med. Chem. Commun., 2012, 3, 829-835
DOI: 10.1039/C2MD00317A

Oxadiazole isomers: all bioisosteres are not created equal
Kristin Goldberg, Sam Groombridge, Julian Hudson, Andrew G. Leach, Philip A. MacFaul, Adrian Pickup, Ruth Poultney, James S. Scott, Per H. Svensson and Joseph Sweeney
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C2MD20054F

Why not take a look at the articles today and blog your thoughts and comments below.

Fancy submitting an article to MedChemComm? Then why not submit to us today or alternatively email us your suggestions.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Delivering insulin in a skin cream

Insulin could be administered topically rather than by needles in the future

Scientists in Japan have developed a way to administer insulin to patients through the skin. Such a method avoids one of the problems associated with injections and oral administration in which a drug’s concentration is reduced as it passes through the digestive system. It would also be a more pleasant experience for patients.

Masahiro Goto from Kyushu University in Fukuoka and SO Pharmaceutical Corporation in Kobe, and colleagues, prepared a capsule loaded with insulin that is able to penetrate the skin with its cargo.

The team made their capsule by surrounding insulin molecules with proteins and coating the protein molecules with a hydrophobic surfactant to form protein–surfactant complexes. Then, they added oligo-arginine peptides as protein transduction domains and dispersed the complexes in oil – isopropyl myristate – which is known to have a permeation-enhancing effect. ‘The main function of this new system is to promote protein penetration through the hydrophobic stratum corneum [outermost layer of the skin],’ explains Goto.

The team tested their delivery vehicle on pig skin and found that the solid-in-oil dispersion delivered six times more insulin into the skin than an aqueous solution. The peptides further enhanced the concentration of insulin delivered through the skin.

‘Transcutaneous protein delivery is a difficult problem, the solution of which could enhance the quality of life for patients in need of protein therapeutics,’ says Paschalis Alexandridis from the chemical and biological engineering department at the University of Buffalo, US, whose work includes pharmaceutical formulations. He adds that Goto’s work demonstrates the versatility of solid-in-oil nanodispersions as a platform for enhanced transdermal delivery of protein therapeutics and vaccines.

Goto and his team say that in theory such dispersion could be used for any drug that is soluble in water and can form a water-in-oil emulsion. They hope to be able to produce a transdermal vaccine in the future.

Original story from Chemistry World, written by Jennifer Newton

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Natural product-like cyclic peptide libraries by biochemical & biosynthetic preparation

Albert A. Bowers, Purdue University, provides a review focussing on emerging biochemical and biosynthetic methods for the development of peptidomimetic libraries, in particular constrained cyclic peptide libraries that contain natural product-like features, with an emphasis given to small molecules of 30 residues or less.

Discussion includes:

  • Non-ribosomal peptide synthetases (NRPS) or hybrid polyketide (NRPS/PKS) derived libraries
  • Ribosomal peptide libraries
  • Non-natural product-based technologies for library preparation

Want to know more? Have a look now and let us know your thoughts…

Biochemical and biosynthetic preparation of natural product-like cyclic peptide libraries
Albert A. Bowers
DOI: 10.1039/C2MD20068F

This review is part of MedChemComm’s soon to be published Natural Products themed issue, guest-edited by Prof. Christopher Walsh and Dr Sylvie Garneau-Tsodikova.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

The unusual case of a diterpenoid produced by Mycobacterium tuberculosis and its role in human infection

Reuben J. Peters  (Iowa State University) and Francis Mann (Winona Sate University) provide a short and topical account of the discovery of the isotuberculosinol diterpenoid prodution by bacteria Mycobacterium tuberculosis (Mtb).

The authors review the recent findings showing evidence of the biological role of this diterpenoid in the infection process of Mtb. Based on genetic and genomic analysis, the authors also provide insight into the origin of the tuberculosinol gene cluster and its role in human infection.

Curious? Why not read the review article now and let us know what you think…

Isotuberculosinol: the unusual case of an immunomodulatory diterpenoid from Mycobacterium tuberculosis
Francis M. Mann and Reuben J. Peters
DOI: 10.1039/C2MD20030A

This review is part of MedChemComm’s Natural Products themed issue, guest-edited by Prof. Christopher Walsh and Dr Sylvie Garneau-Tsodikova.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Submit a poster for Lipids and Membrane Biophysics: Faraday Discussion 161

There’s still just time to submit a poster for Lipids and Membrane Biophysics: Faraday Discussion 161 – by the deadline date 13 July.

This Faraday Discussion will consider recent developments in the study of biomembrane structure, ordering and dynamics, with particular emphasis on the roles of lipids in these phenomena. Registration is quick and simple via our online booking system, so act today and benefit from early bird savings.

Why choose to come to a Faraday Discussion? They have a unique format – all papers are circulated in advance and all discussion contributions are recorded for publication in the abstract book after the event. You can also have your own poster space at the meeting, so submit yours now before the deadline of 13 July.

Come and discuss new experimental and theoretical findings and novel methodologies, as we focus on exploring the relevance of concepts from amphiphile self-assembly and soft matter physics to understanding biomembranes.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Top ten most accessed articles in May

This month sees the following articles in MedChemComm that are in the top ten most accessed:

The use of phosphate bioisosteres in medicinal chemistry and chemical biology
Thomas S. Elliott, Aine Slowey, Yulin Ye and Stuart J. Conway
Med. Chem. Commun., 2012, 3, 735-751
DOI: 10.1039/C2MD20079A

Minisci reactions: Versatile CH-functionalizations for medicinal chemists
Matthew A. J. Duncton
Med. Chem. Commun., 2011, 2, 1135-1161
DOI: 10.1039/C1MD00134E

Gd(III) chelates for MRI contrast agents: from high relaxivity to “smart”, from blood pool to blood–brain barrier permeable
Chang-Tong Yang and Kai-Hsiang Chuang
Med. Chem. Commun., 2012, 3, 552-565
DOI: 10.1039/C2MD00279E

Enantiomeric pairs reveal that key medicinal chemistry parameters vary more than simple physical property based models can explain
Andrew G. Leach, Elizabeth A. Pilling, Alfred A. Rabow, Simone Tomasi, Nabil Asaad, Niklaas J. Buurma, Andrew Ballard and Stefania Narduolo
Med. Chem. Commun., 2012, 3, 528-540
DOI: 10.1039/C2MD20010D

Small-molecule inhibitors of dimeric transcription factors: Antagonism of protein–protein and protein–DNA interactions
Jeremy L. Yap, Jay Chauhan, Kwan-Young Jung, Lijia Chen, Edward V. Prochownik and Steven Fletcher
Med. Chem. Commun., 2012, 3, 541-551
DOI: 10.1039/C2MD00289B

Oxadiazole isomers: all bioisosteres are not created equal
Kristin Goldberg, Sam Groombridge, Julian Hudson, Andrew G. Leach, Philip A. MacFaul, Adrian Pickup, Ruth Poultney, James S. Scott, Per H. Svensson and Joseph Sweeney
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C2MD20054F

Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space
Alexander Alex, David S. Millan, Manuel Perez, Florian Wakenhut and Gavin A. Whitlock
Med. Chem. Commun., 2011, 2, 669-674
DOI: 10.1039/C1MD00093D

Molecular obesity, potency and other addictions in drug discovery
Michael M. Hann
Med. Chem. Commun., 2011, 2, 349-355
DOI: 10.1039/C1MD00017A

Biochemical and biosynthetic preparation of natural product-like cyclic peptide libraries
Albert A. Bowers
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C2MD20068F

Biosynthetic medicinal chemistry of natural product drugs
Frank E. Koehn
Med. Chem. Commun., 2012, Advance Article
DOI: 10.1039/C2MD00316C

Why not take a look at the articles today and blog your thoughts and comments below.

Fancy submitting an article to MedChemComm? Then why not submit to us today or alternatively email us your suggestions.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

2011 Impact Factor for OBC, MedChemComm & NPR

The 2011 Journal Citation Reports ® (Thomson Reuters, 2012) have just been released, which showed:

Organic & Biomolecular Chemistry: 3.696

MedChemComm: 2.8         (Partial IF only, based on five issues)

Natural Product Reports: 9.79

The Cambridge Editorial Office would like to thank everyone involved for their hard work and dedication to all three journals over the years. In particular, we would like to thank all of our Associate Editors, Editorial and Advisory Board members, authors and referees, without whom none of this would have been possible.

With another successful year in the bag, we hope you will join us in making this year even better…

Read more about the 2011 Impact Factors from across RSC Publishing on the RSC Publishing Blog.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)